Latham & Watkins Advises Inovalon in US$7.3 Billion Acquisition by Equity Consortium Led by Nordic Capital Including Insight Partners

A multidisciplinary deal team is advising the provider of cloud-based platforms empowering data driven healthcare.

August 19, 2021

Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, has announced that it has entered into a definitive agreement to be acquired by an equity consortium led by Nordic Capital, and joined by Insight Partners, as lead co-investor, 22C Capital, and Inovalon founder and Chief Executive Officer Keith Dunleavy, M.D. and certain Class B stockholders of Inovalon in an all-cash transaction with an enterprise value of approximately US$7.3 billion.

Latham & Watkins LLP represents Inovalon and the Special Committee of the Board of Directors of Inovalon in the transaction with a M&A team led by New York partners David Allinson and Peter Harwich, with associates Leah Sauter, Jack Welch, and Sophia Choi. Advice was also provided on tax matters by New York partner David Raab, with associate Shruti Hazra; on benefits and compensation matters by New York partner Jennifer Pepin, with associates Megan Alessi, Madeline Hong, and Laura Waller; on intellectual property matters by New York partner Steven Betensky, with associate Morgan Brubaker; on data privacy matters by Bay Area counsel Robert Blamires, with associate Adriana Beach; on healthcare regulatory matters by Washington, D.C. partner Stuart Kurlander, Los Angeles counsel Jennifer Yoo, and Bay Area counsel Heather Deixler; on antitrust matters by Washington, D.C. partner Alan Devlin, with associate Christopher Brown; on CFIUS matters by Washington, D.C. partner Damara Chambers; and on finance matters by New York partner Joshua Tinkelman.

 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.